Patients' Affinity for AI Messages Drops if they Know the Technology was Used

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human. That preference was diminished, though not erased, when told AI was involved.

The study, publishing March 11 in JAMA Network Open, showed high overall satisfaction with communications written both by AI and humans, despite their preference for AI. This suggests that letting patients know AI was used does not greatly reduce confidence in the message.

"Every health system is grappling with this issue of whether we disclose the use of AI and how," said senior author Anand Chowdhury, M.D., assistant professor in the Department of Medicine at Duke University School of Medicine. "There is a desire to be transparent, and a desire to have satisfied patients. If we disclose AI, what do we lose? That is what our study intended to measure."

Chowdhury and colleagues sent a series of surveys to members of the Duke University Health System patient advisory committee. This is a group of Duke Health patients and community members who help inform how Duke Health communicates with and cares for patients. More than 1,400 people responded to at least one of the surveys.

The surveys focused on three clinical topics, including routine medication refill request (a low seriousness topic), medication side effect question (moderate seriousness), and potential cancer on imaging (high seriousness).

Human responses were provided by a multidisciplinary team of physicians who were asked to write a realistic response to each survey scenario based on how they typically draft responses to patients. The generative AI responses were written using ChatGPT and were reviewed for accuracy by the study physicians who made minimal changes to the responses.

For each survey, participants were asked to review a vignette that presented one of the clinical topics. Each vignette included a response from either AI or human clinicians, along with either a disclosure or no disclosure telling them who the author was. They were then asked to rate their overall satisfaction with the response, usefulness of the information, and how cared for they felt during the interaction.

Comparing authors, patients preferred AI-drafted messages by an average difference of 0.30 points on 5-point scale for satisfaction. The AI communications tended to be longer, included more details, and likely seemed more empathetic than human-drafted messages.

"Our study shows us that patients have a slight preference for messages written by AI, even though they are slightly less satisfied when the disclosure informs them that AI was involved," said first author Joanna S. Cavalier, M.D., assistant professor in the Department of Medicine at Duke University School of Medicine.

When they looked at the difference in satisfaction when participants were told AI was involved, disclosing AI led to lower satisfaction, though not by much: 0.1 points on the 5-point scale. Regardless of the actual author, patients were overall more satisfied with messages when they were not told AI was involved in drafting the response.

"These findings are particularly important in the context of research showing that patients have higher satisfaction when they can connect electronically with their clinicians," Chowdhury said.

"At the same time, clinicians express burnout when their in-basket is full, making the use of automated tools highly attractive to ease that burden," Chowdhury said. "Ultimately these findings give us confidence to use technologies like this to potentially help our clinicians reduce burnout, while still doing the right thing and telling our patients when we use AI."

Cavalier JS, Goldstein BA, Ravitsky V, Bélisle-Pipon JC, Bedoya A, Maddocks J, Klotman S, Roman M, Sperling J, Xu C, Poon EG, Chowdhury A.
Ethics in Patient Preferences for Artificial Intelligence-Drafted Responses to Electronic Messages.
JAMA Netw Open. 2025 Mar 3;8(3):e250449. doi: 10.1001/jamanetworkopen.2025.0449

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...